ATG7 and metabolic dysfunction-associated steatohepatitis: In the “ferroptosis” pathway, four genes (CP, SLC3A2, SLC11A2, and ACSL5) had lower expression in NASH and two genes (ATG7 and ACSL4) had higher expression.